Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Engaging innate immunity in HIV-1 cure strategies.
Nat Rev Immunol. 2022 Aug;22(8):499-512. doi: 10.1038/s41577-021-00649-1. Epub 2021 Nov 25.
Nat Rev Immunol. 2022.
PMID: 34824401
Review.
TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Sengupta S, Board NL, Wu F, Moskovljevic M, Douglass J, Zhang J, Reinhold BR, Duke-Cohan J, Yu J, Reed MC, Tabdili Y, Azurmendi A, Fray EJ, Zhang H, Hsiue EH, Jenike K, Ho YC, Gabelli SB, Kinzler KW, Vogelstein B, Zhou S, Siliciano JD, Sadegh-Nasseri S, Reinherz EL, Siliciano RF.
Sengupta S, et al. Among authors: board nl.
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2123406119. doi: 10.1073/pnas.2123406119. Epub 2022 Apr 8.
Proc Natl Acad Sci U S A. 2022.
PMID: 35394875
Free PMC article.
Item in Clipboard
A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.
Sengupta S, Zhang J, Reed MC, Yu J, Kim A, Boronina TN, Board NL, Wrabl JO, Shenderov K, Welsh RA, Yang W, Timmons AE, Hoh R, Cole RN, Deeks SG, Siliciano JD, Siliciano RF, Sadegh-Nasseri S.
Sengupta S, et al. Among authors: board nl.
J Exp Med. 2023 Jul 3;220(7):e20221654. doi: 10.1084/jem.20221654. Epub 2023 Apr 14.
J Exp Med. 2023.
PMID: 37058141
Free PMC article.
Item in Clipboard
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells.
Board NL, Yuan Z, Wu F, Moskovljevic M, Ravi M, Sengupta S, Mun SS, Simonetti FR, Lai J, Tebas P, Lynn K, Hoh R, Deeks SG, Siliciano JD, Montaner LJ, Siliciano RF.
Board NL, et al.
Nat Immunol. 2024 Mar;25(3):462-470. doi: 10.1038/s41590-023-01741-5. Epub 2024 Jan 26.
Nat Immunol. 2024.
PMID: 38278966
Free PMC article.
Item in Clipboard
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR.
Ogega CO, et al. Among authors: board nl.
PLoS Pathog. 2022 Jan 6;18(1):e1010179. doi: 10.1371/journal.ppat.1010179. eCollection 2022 Jan.
PLoS Pathog. 2022.
PMID: 34990486
Free PMC article.
Item in Clipboard
Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine.
Tariq Z, Board N, Eftimiades A, Ibrahim R.
Tariq Z, et al.
SAGE Open Med Case Rep. 2019 May 6;7:2050313X19847804. doi: 10.1177/2050313X19847804. eCollection 2019.
SAGE Open Med Case Rep. 2019.
PMID: 31105954
Free PMC article.
Item in Clipboard
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.
Bu W, Kumar A, Board NL, Kim J, Dowdell K, Zhang S, Lei Y, Hostal A, Krogmann T, Wang Y, Pittaluga S, Marcotrigiano J, Cohen JI.
Bu W, et al. Among authors: board nl.
Immunity. 2024 Mar 12;57(3):559-573.e6. doi: 10.1016/j.immuni.2024.02.008.
Immunity. 2024.
PMID: 38479361
Item in Clipboard
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
Chen WH, Kim J, Bu W, Board NL, Tsybovsky Y, Wang Y, Hostal A, Andrews SF, Gillespie RA, Choe M, Stephens T, Yang ES, Pegu A, Peterson CE, Fisher BE, Mascola JR, Pittaluga S, McDermott AB, Kanekiyo M, Joyce MG, Cohen JI.
Chen WH, et al. Among authors: board nl.
Immunity. 2022 Nov 8;55(11):2135-2148.e6. doi: 10.1016/j.immuni.2022.10.003. Epub 2022 Oct 27.
Immunity. 2022.
PMID: 36306784
Free PMC article.
Item in Clipboard
Cite
Cite